Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Hits Snooze On Remanufacturing Draft Guidance, Cybersecurity Discussion Paper

Executive Summary

The US agency is extending public comment periods for a controversial draft guidance and a cybersecurity servicing paper that caution servicers that they could get in hot water for remanufacturing medical devices.

You may also be interested in...

Software Servicers Can Help Keep Products On Market After Manufacturers Stop Providing Support: US FDA

The agency issued a discussion paper that lays out how third-party servicers could help mitigate cybersecurity threats and keep products on the market.

FDA: Companies Servicing Products Could Get In Hot Water For Remanufacturing

A new draft guidance from the US FDA clarifies what it considers to be remanufacturing. Companies remanufacturing devices are regulated by the agency and may require new premarket applications.

Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts